This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Dec;59(12):1728-9; author reply 1729-30.

doi: 10.1136/gut.2009.194100. Epub 2010 Aug 23.

Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activity

Marko Brinar, Isabelle Cleynen, Tamara Coopmans, Gert Van Assche, Paul Rutgeerts, Severine Vermeire

PMID: 20732921
DOI: 10.1136/gut.2009.194100

Comment

Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activity

Marko Brinar et al. Gut. 2010 Dec.

. 2010 Dec;59(12):1728-9; author reply 1729-30.

doi: 10.1136/gut.2009.194100. Epub 2010 Aug 23.

Authors

Marko Brinar, Isabelle Cleynen, Tamara Coopmans, Gert Van Assche, Paul Rutgeerts, Severine Vermeire

PMID: 20732921
DOI: 10.1136/gut.2009.194100

No abstract available

PubMed Disclaimer

Comment on

Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease.
Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, Roth J. Foell D, et al. Gut. 2003 Jun;52(6):847-53. doi: 10.1136/gut.52.6.847. Gut. 2003. PMID: 12740341 Free PMC article.

Similar articles

Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease.
Leach ST, Yang Z, Messina I, Song C, Geczy CL, Cunningham AM, Day AS. Leach ST, et al. Scand J Gastroenterol. 2007 Nov;42(11):1321-31. doi: 10.1080/00365520701416709. Scand J Gastroenterol. 2007. PMID: 17852869
Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
Foell D, Wittkowski H, Ren Z, Turton J, Pang G, Daebritz J, Ehrchen J, Heidemann J, Borody T, Roth J, Clancy R. Foell D, et al. J Pathol. 2008 Oct;216(2):183-92. doi: 10.1002/path.2394. J Pathol. 2008. PMID: 18729068
Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.
Wittkowski H, Hirono K, Ichida F, Vogl T, Ye F, Yanlin X, Saito K, Uese K, Miyawaki T, Viemann D, Roth J, Foell D. Wittkowski H, et al. Arthritis Rheum. 2007 Dec;56(12):4174-81. doi: 10.1002/art.23042. Arthritis Rheum. 2007. PMID: 18050248
Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage.
Foell D, Wittkowski H, Roth J. Foell D, et al. Gut. 2009 Jun;58(6):859-68. doi: 10.1136/gut.2008.170019. Epub 2009 Jan 9. Gut. 2009. PMID: 19136508 Review.
Established and emerging biological activity markers of inflammatory bowel disease.
Nielsen OH, Vainer B, Madsen SM, Seidelin JB, Heegaard NH. Nielsen OH, et al. Am J Gastroenterol. 2000 Feb;95(2):359-67. doi: 10.1111/j.1572-0241.2000.t01-1-01790.x. Am J Gastroenterol. 2000. PMID: 10685736 Review.

See all similar articles

Cited by

IL-22 is induced by S100/calgranulin and impairs cholesterol efflux in macrophages by downregulating ABCG1.
Chellan B, Yan L, Sontag TJ, Reardon CA, Hofmann Bowman MA. Chellan B, et al. J Lipid Res. 2014 Mar;55(3):443-54. doi: 10.1194/jlr.M044305. Epub 2013 Dec 23. J Lipid Res. 2014. PMID: 24367046 Free PMC article.
The role of S100A12 as a systemic marker of inflammation.
Meijer B, Gearry RB, Day AS. Meijer B, et al. Int J Inflam. 2012;2012:907078. doi: 10.1155/2012/907078. Epub 2012 Jul 3. Int J Inflam. 2012. PMID: 22811950 Free PMC article.
Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis.
Vilela EG, Torres HO, Martins FP, Ferrari Mde L, Andrade MM, Cunha AS. Vilela EG, et al. World J Gastroenterol. 2012 Mar 7;18(9):872-81. doi: 10.3748/wjg.v18.i9.872. World J Gastroenterol. 2012. PMID: 22408345 Free PMC article. Review.
Uncovering common disease mechanisms and critical biomarkers in Crohn's disease with concurrent psoriasis and exploring potential therapeutic agents.
Liu T, Zhang X, Chen R, Sun Y, Zhang R, Zhang L, Luo Z, Wang J. Liu T, et al. PLoS One. 2025 Jun 20;20(6):e0324007. doi: 10.1371/journal.pone.0324007. eCollection 2025. PLoS One. 2025. PMID: 40540498 Free PMC article.
Atorvastatin Reduces Circulating S100A12 Levels in Patients with Carotid Atherosclerotic Plaques - A Link with Plaque Inflammation.
Komatsu T, Ayaori M, Uto-Kondo H, Hayashi K, Tamura K, Sato H, Sasaki M, Nishida T, Takiguchi S, Yakushiji E, Nakaya K, Ikewaki K. Komatsu T, et al. J Atheroscler Thromb. 2022 May 1;29(5):775-784. doi: 10.5551/jat.61630. Epub 2021 May 1. J Atheroscler Thromb. 2022. PMID: 33952812 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal